Risk Factors for Gastric Antral Vascular Ectasia (GAVE)
GAVE is strongly associated with liver disease and portal hypertension, chronic kidney disease, connective tissue disorders, and features of metabolic syndrome including diabetes, obesity, and vascular disease. 1
Primary Risk Factors
Liver Disease and Portal Hypertension
- Cirrhosis is the most prevalent association, present in 64% of GAVE patients 2
- GAVE accounts for approximately 6% of gastrointestinal bleeding in cirrhotic patients 1
- Non-alcoholic steatohepatitis (NASH) cirrhosis carries particularly high risk, with GAVE occurring in 29.2% of NASH cirrhosis patients versus only 9.4% in other cirrhosis etiologies 3
- NASH cirrhosis shows an odds ratio of 3.73 for GAVE development, and 5.77 for symptomatic GAVE 3
Metabolic Syndrome Components
Recent evidence has revealed a strong correlation between GAVE and metabolic syndrome features 2:
- Diabetes mellitus: present in 64% of GAVE patients versus 29% of controls (p<0.001) 2
- Elevated BMI: mean BMI of 33.7 kg/m² in GAVE patients versus 28.8 kg/m² in controls (p<0.001) 2
- Vascular disease: present in 57% of GAVE patients versus 36% of controls (p<0.001) 2
Chronic Kidney Disease
- Chronic kidney disease is recognized as an associated condition 1, 4
- Hemodialysis patients may develop GAVE as part of multimorbid presentations 5
Connective Tissue Disorders
Autoimmune and connective tissue diseases are important associations 1:
- Systemic sclerosis (scleroderma) shows distinct patterns:
- Diffuse cutaneous SSc develops GAVE earlier (mean 21.5 months from disease onset) 6
- Limited cutaneous SSc develops GAVE later (mean 84.3 months) 6
- 76% of diffuse SSc patients develop GAVE within 18 months of first symptom 6
- Rapid progression of cutaneous disease predicts earlier GAVE development 6
- RNA polymerase III antibodies may be overrepresented in GAVE patients 6
- Absence of antitopoisomerase I antibodies may identify higher-risk patients 6
- Other autoimmune conditions: Raynaud's phenomenon, sclerodactyly, Sjögren's syndrome, systemic lupus erythematosus, primary biliary cirrhosis 4, 7
Cardiac Disease
- Aortic stenosis confers a 2-fold increased risk of GAVE development (OR: 2.08, p<0.001) 8
- Cardiac diseases in general are recognized associations 4
- Post-transcatheter aortic valve implantation (TAVI) patients may develop GAVE 5
Other Risk Factors
Important Clinical Caveats
GAVE is commonly misdiagnosed as portal hypertensive gastropathy, gastritis, or other conditions 1. This is particularly problematic because GAVE can coexist with portal hypertensive gastropathy in approximately 30% of cirrhotic patients 4.
In patients with "burned-out" metabolic dysfunction-associated steatotic liver disease, refractory GAVE may serve as a sentinel sign for occult hepatocellular carcinoma and advancing portal hypertension, even when imaging shows deceptive steatosis regression 5.
GAVE may precede other clinical manifestations of systemic sclerosis by 7-8 years, presenting initially as unexplained iron-deficiency anemia requiring transfusions 7. Therefore, patients with idiopathic or recurrent GAVE warrant evaluation for underlying connective tissue disease.